scispace - formally typeset
J

Jacques Ferlay

Researcher at International Agency for Research on Cancer

Publications -  145
Citations -  276378

Jacques Ferlay is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 69, co-authored 129 publications receiving 211074 citations.

Papers
More filters
Journal Article

Head and neck cancer: a global perspective on epidemiology and prognosis.

TL;DR: The overall incidence rates show a declining trend in both sexes in India, Hong Kong, Brazil and US whites, an increasing trend is observed in most other populations, particularly in Central and Eastern Europe, Scandinavia, Canada, Japan and Australia.

Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening.

TL;DR: Community action shall cover the fight against the major health scourges, by promoting L 327/34 Official Journal of the European Union 16.12.2003 Population-based, Nationwide Rollout complete.
Journal ArticleDOI

Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study

TL;DR: The global cancer burden among 20-39 year-olds differs from that seen in younger or older ages and varies substantially by age, sex, development level, and geographical region; generally, the burden of infection-associated cancers was greater in regions under transition.
Journal ArticleDOI

Comprehensive control of human papillomavirus infections and related diseases.

F. Xavier Bosch, +98 more
- 22 Nov 2013 - 
TL;DR: There must be ongoing efforts including international advocacy to achieve widespread-optimally universal-implementation of HPV prevention strategies in both developed and developing countries.
Journal Article

The global health burden of infection associated cancers

TL;DR: Several infectious agents are considered to be causes of cancer in humans as mentioned in this paper, including Helicobacter pylori (5.5%), hepatitis B and C viruses (4.9%), Epstein-Barr virus (1%), human immunodeficiency virus (HIV) together with the human herpes virus 8 (0.9%).